Artwork

Content provided by Dr. Jeff Sankoff. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Jeff Sankoff or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep 131: Ozempic/Edward O'Malley designer of the Velo Vetta bike shoe

1:03:30
 
Share
 

Manage episode 381961160 series 2837525
Content provided by Dr. Jeff Sankoff. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Jeff Sankoff or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode:

Ozempic and Wegovy, both trade names of the drug semaglutide have led a kind of weight loss revolution because of the success patients who use them have had in dropping and keeping off weight. The mechanism by which this drug works does have some consequences for any multisport athletes who use or are considering using it and so on the medical mailbag we look at this drug and what multisport athletes should know. Edward O'Malley is an engineer and age group triathlete who saw a need for a better bike shoe so he designed one himself and the result is the VeloVetta. With its unique closure lever and aerodynamic features the shoe has some real promise for making your transitions and bike splits faster. Meet the man behind the shoe and hear why he did what he did.

Segments:

[03:53]- Medical Mailbag:

[32:52]- Interview: Edward O'Malley

Links

Edward's Facebook page

@velovetta on Instagram

Edward's Website

Edward on YouTube

  continue reading

150 episodes

Artwork
iconShare
 
Manage episode 381961160 series 2837525
Content provided by Dr. Jeff Sankoff. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Jeff Sankoff or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode:

Ozempic and Wegovy, both trade names of the drug semaglutide have led a kind of weight loss revolution because of the success patients who use them have had in dropping and keeping off weight. The mechanism by which this drug works does have some consequences for any multisport athletes who use or are considering using it and so on the medical mailbag we look at this drug and what multisport athletes should know. Edward O'Malley is an engineer and age group triathlete who saw a need for a better bike shoe so he designed one himself and the result is the VeloVetta. With its unique closure lever and aerodynamic features the shoe has some real promise for making your transitions and bike splits faster. Meet the man behind the shoe and hear why he did what he did.

Segments:

[03:53]- Medical Mailbag:

[32:52]- Interview: Edward O'Malley

Links

Edward's Facebook page

@velovetta on Instagram

Edward's Website

Edward on YouTube

  continue reading

150 episodes

Todos os episódios

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide